BIODIVERSITY OF VIETNAM AND LAOS

描述：(申请人描述) 人均国内生产总值约为1140美元， 人类发展指数(HDI)在175个国家中排名121，越南是其中之一 世界上最不发达的国家。同样，老挝的国内生产总值为 850美元，而HDI排名为136分(满分175分)，是另一个排名最低的 发达国家。这两个国家都拥有高度的热带生物多样性。 然而，这些丰富的生物多样性正受到威胁：森林砍伐的速度 据估计，越南的面积为600平方公里/年，老挝的面积为1000平方公里/年。 显然，无论这两个国家各自的热带生物多样性如何 HAS必须受到保护，作为一种资源，必须对其进行调查 经济潜力。证明这些森林可以提供新的 国家的药品和一般收入将有助于加强 保护这些高度多样化的生态系统的事业。鉴于长期的- 组织之间存在的长期关系 合作研究计划首席研究员 伊利诺伊大学芝加哥分校的药学 (PCRPS/LAC)，以及越南的两个研究机构，国家中心 自然科学与技术和Cuc Phuong国家公园，On 一方面，以及在PCRPS/UIC和研究所之间 另一方面，老挝的药用植物提出了一项建议，以实施 一项最初为期五年的合作研究。长期的 这项研究的目标是(1)对以下各项进行书面盘点 这些国家的热带森林植物多样性和药用植物 (越南CUC Phuong国家公园，以及 老挝有选择的部落群体)；(2)从生物学上发现新的 来自两国植物的活性分子可能是候选者 用于治疗疟疾、病毒性疾病的药物开发 (3)提高标准； 所研究的部落社区成员的生活，以及 一般国家，通过社区教育和生物质生产 已被确认为具有良好的经济价值的植物 潜力，特别是药用潜力。工业合作伙伴葛兰素史克 英国史蒂夫尼奇的Wellcome研发有限公司将加强 这个以PCRPS/UIC为基础的国际合作生物多样性组织(ICBG)。

DESCRIPTION: (Applicant's Description) With a Gross Domestic Product (GDP) of about $1,140 per capita, and a Human Development Index (HDI) ranking of 121 out of 175, Vietnam is one of the least developed nations in the world. Similarly, Laos, with a GDP of $850 and a HDI ranking of 136 out of 175, is another of the least developed nations. Both countries possess a high tropical biodiversity. Yet these rich biodiversities are under threat: the rate of deforestation is estimated at 600 sq km/year for Vietnam, and 1,00 sq km/year for Laos. Clearly, whatever tropical biodiversity each of these two countries still has must be protected, and, as a resource, must be investigated for its economic potential. A demonstration that these forests could provide new medicines and general revenue for the country would help strengthen the cause of protecting these highly diverse ecosystems. In view of a long- standing relationship that exists between the organization of the Principal Investigator, the Program for Collaborative Research in the Pharmaceutical Sciences at the University of Illinois at Chicago (PCRPS/LAC), and two research institutions in Vietnam, the National Center for Natural Sciences and Technology and the Cuc Phuong National Park, on the one hand, and between the PCRPS/UIC and the Research Institute for Medicinal Plants in Laos, on the other, a proposal is made to carry out a collaborative study for an initial period of five years. The long-term objectives of the study are (1) to undertake a documented inventory of tropical forest plant diversity and medicinal plant use in these countries (Cuc Phuong National Park in Vietnam, and ethnobotanical surveys of selective tribal groups in Laos); (2) to discovered novel biologically active molecules from plants from both countries as possible candidates for drug development in the treatment of malaria, viral diseases (including AIDS) and CNS-related diseases; and (3) to improve the standard of living of the members of the tribal communities studied, and of the countries in general, through community education and biomass production of plants that have been identified as having promising economic potential, particularly medicinal potential. An industrial partner, Glaxo Wellcome Research and Development Limited, Stevenage, UK, will strengthen this PCRPS/UIC-based International Cooperative Biodiversity Group (ICBG).